KR910002534B1 - 셀레늄 유기화합물의 제조방법 - Google Patents

셀레늄 유기화합물의 제조방법 Download PDF

Info

Publication number
KR910002534B1
KR910002534B1 KR1019830002383A KR830002383A KR910002534B1 KR 910002534 B1 KR910002534 B1 KR 910002534B1 KR 1019830002383 A KR1019830002383 A KR 1019830002383A KR 830002383 A KR830002383 A KR 830002383A KR 910002534 B1 KR910002534 B1 KR 910002534B1
Authority
KR
South Korea
Prior art keywords
selenium
tsel
mice
rats
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830002383A
Other languages
English (en)
Korean (ko)
Other versions
KR840004760A (ko
Inventor
레비키 엠마뉴엘
Original Assignee
에프. 씨. 엔. 에스. 알. 엘.,
기암피에로 캐도나티
알파타임 리미티드 캄파니 인코포레이티드
엘레나 에이브람, 맥심 아사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT8221552A external-priority patent/IT8221552A0/it
Priority claimed from IT20672/83A external-priority patent/IT1164188B/it
Application filed by 에프. 씨. 엔. 에스. 알. 엘.,, 기암피에로 캐도나티, 알파타임 리미티드 캄파니 인코포레이티드, 엘레나 에이브람, 맥심 아사 filed Critical 에프. 씨. 엔. 에스. 알. 엘.,
Publication of KR840004760A publication Critical patent/KR840004760A/ko
Application granted granted Critical
Publication of KR910002534B1 publication Critical patent/KR910002534B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00—Compounds containing selenium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D345/00—Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electroluminescent Light Sources (AREA)
KR1019830002383A 1982-05-28 1983-05-27 셀레늄 유기화합물의 제조방법 Expired KR910002534B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IT8221552A IT8221552A0 (it) 1982-05-28 1982-05-28 Nuovi composti ad attivita'antineoplastica, procedimetno per la loro preparazione e relative composizioni farmaceutiche.
IT21552 1982-05-28
IT21552A/82 1982-05-28
IT20672/83A IT1164188B (it) 1983-04-19 1983-04-19 Nuovi composti ad attivita' antineoplastica,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT20672 1983-04-19

Publications (2)

Publication Number Publication Date
KR840004760A KR840004760A (ko) 1984-10-24
KR910002534B1 true KR910002534B1 (ko) 1991-04-23

Family

ID=26327610

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830002383A Expired KR910002534B1 (ko) 1982-05-28 1983-05-27 셀레늄 유기화합물의 제조방법

Country Status (18)

Country Link
US (1) US4564634A (enExample)
EP (1) EP0095663B1 (enExample)
KR (1) KR910002534B1 (enExample)
AR (1) AR230421A1 (enExample)
AU (1) AU552556B2 (enExample)
CA (1) CA1197255A (enExample)
DE (1) DE3361690D1 (enExample)
DK (1) DK241183A (enExample)
ES (1) ES522757A0 (enExample)
FI (1) FI78070C (enExample)
GR (1) GR77469B (enExample)
IE (1) IE54929B1 (enExample)
IN (1) IN157041B (enExample)
NO (1) NO157505C (enExample)
NZ (1) NZ204394A (enExample)
PH (1) PH24229A (enExample)
PT (1) PT76767B (enExample)
YU (1) YU44975B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101588441B1 (ko) * 2015-07-22 2016-02-03 정재락 유기 셀레늄의 제조방법

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1161213B (it) * 1983-03-08 1987-03-18 Fcn Srl Composizioni farmaceutiche ad attivita' antineoplastica
US4824955A (en) * 1985-11-15 1989-04-25 Nippon Kayaku Kabushiki Kaisha Selenium oxy chloride-pyridine or bipyridine complexes
CH676667A5 (enExample) * 1988-03-07 1991-02-28 Onco Pharm Dev Ag
WO1990003175A1 (en) * 1988-09-27 1990-04-05 Avram, Elena Selenium compositions for treatment of disease
DE4320694C2 (de) * 1993-06-22 1999-11-11 Biosyn Arzneimittel Gmbh Vewendung von Selenverbindungen zur äußeren Anwendung bei Warzen
RU2176916C1 (ru) * 2001-01-22 2001-12-20 Новицкий Юрий Алексеевич Селеновое гликопротеиновое элементорганическое вещество, обладающее иммуностимулирующим действием (его варианты)
RU2177321C1 (ru) * 2001-01-22 2001-12-27 Новицкий Юрий Алексеевич Селеновое каротинопротеиновое органическое вещество для регулирования метаболических процессов (его варианты)
US6632837B1 (en) * 2002-10-21 2003-10-14 Elena Avram Compositions containing a selenium monobromide-oil reaction product and epichlorohydrin and methods of making the same
JP2006528696A (ja) * 2003-05-13 2006-12-21 ヘルス　リサーチ　インコーポレイテッド 抗癌剤の抗腫瘍活性を増強する方法
US20050197399A1 (en) * 2003-05-13 2005-09-08 Marwan Fakih Method of augmenting the antitumor activity of anticancer agents
US20060258697A1 (en) * 2003-05-13 2006-11-16 Rustum Youcef M Method of augmenting the antitumor activity of anticancer agents
US7534818B1 (en) 2003-09-15 2009-05-19 Health Research, Inc. Method of reducing alopecia and bladder toxicity of cyclophosphamide
CN1329519C (zh) * 2006-03-29 2007-08-01 王景恒 富含有机硒的γ－亚麻酸干菌粉及其生产工艺

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2152642A (en) * 1939-04-04 Treatment of teng oil

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101588441B1 (ko) * 2015-07-22 2016-02-03 정재락 유기 셀레늄의 제조방법

Also Published As

Publication number Publication date
YU118683A (en) 1986-04-30
PH24229A (en) 1990-05-04
PT76767A (en) 1983-06-01
KR840004760A (ko) 1984-10-24
DK241183D0 (da) 1983-05-27
YU44975B (en) 1991-06-30
NO157505C (no) 1988-03-30
AU552556B2 (en) 1986-06-05
AR230421A1 (es) 1984-04-30
FI78070B (fi) 1989-02-28
GR77469B (enExample) 1984-09-24
FI78070C (fi) 1989-06-12
FI831857A0 (fi) 1983-05-24
FI831857L (fi) 1983-11-29
US4564634A (en) 1986-01-14
IN157041B (enExample) 1986-01-04
CA1197255A (en) 1985-11-26
DE3361690D1 (en) 1986-02-13
IE831260L (en) 1983-11-28
PT76767B (en) 1986-03-27
DK241183A (da) 1983-11-29
EP0095663B1 (en) 1986-01-02
ES8407321A1 (es) 1984-09-16
ES522757A0 (es) 1984-09-16
NO831870L (no) 1983-11-29
IE54929B1 (en) 1990-03-28
NO157505B (no) 1987-12-21
NZ204394A (en) 1985-08-16
AU1499983A (en) 1983-12-01
EP0095663A1 (en) 1983-12-07

Similar Documents

Publication Publication Date Title
KR910002534B1 (ko) 셀레늄 유기화합물의 제조방법
Schwartz Role of trace elements in cancer
CN111135299A (zh) 光敏剂-低氧激活前药一体化前药自组装纳米粒的构建
Evangelou et al. Comparison of the therapeutic effects of two vanadium complexes administered at low doses on benzo [a] pyrene-induced malignant tumors in rats
US5475030A (en) Complexes of tellurium and selenium derivatives
EP0350801A2 (en) Polyprenols and polyprenyl phosphates for the inhibition of tumour metastasis
JP2023520668A (ja) 薬物二量体を含むナノ粒子、及びその使用
EP0145711A1 (en) Copper complex for treating cancer
KR20080111021A (ko) 철 대사 장애의 치료를 위한 스트로빌루린의 용도
JPH0629191B2 (ja) 抗腫瘍剤、抗ウィルス剤
WO1991017751A1 (en) Orally administrable gallium compositions and methods of treatment therewith
Breidenbach et al. Attempted tumor induction in guinea pigs
CA1036618A (en) Process for the manufacture of tris (2-hydroxyethyl) ammonium-ortho-cresosyacetate
US6541514B2 (en) Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids
EA007481B1 (ru) Цисплатиновые составы пониженной токсичности и способы их применения
Miesel et al. Anticarcinogenic reactivity of copper-dischiffbases with superoxide dismutase-like activity
KR100217001B1 (ko) 3-히드록시-4-피론의 갈륨복합체의 약제학적 조성물
US3852454A (en) Treatment of rheumatoid arthritis
KR0156543B1 (ko) 텔루륨 및 셀레늄 유도체의 착화합물 및 이를 포함하는 약제학적 조성물
WO2004048358A1 (en) Control of cancer with annonaceous extracts
Helfenstein et al. Effect of 2-Methyl-1, 2-bis-(3-pyridyl)-1-propanone (Metyrapone) on the Production of Mammary Tumours induced in Rats by Oral Feeding with Dimethylbenzanthracene
DE2608516A1 (de) Chinoxalin-1,4-dioxid-ester und tierarznei- und wachstumsfoerderungsmittel, die diese verbindungen enthalten
DE3143592C2 (de) Quaternäre N,N↑3↑-Di(ß-brompropionyl)-N',N↑2↑-dispirotripiperaziniumsalze, Verfahren zu deren Herstellung und Arzneimittel mit zytostatischer Wirkung
EP0331917B1 (en) Dialkyl diselenides having an antineoplastic activity
Shamberger Selenium and health

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19940424

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19940424